Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments

Abstract

Nirsevimab can protect a broad infant population against RSV infection with high effectiveness. Approaches including extended catch-up are the most effective, although cost- effectiveness must be considered.